The Neuro's Virtual Integrated Patient Platform receives major funding

Published: 4 June 2026

Brain Canada support will help accelerate the discovery of new treatments for brain and nervous system disorders...

Disease causing mutation found in French-Canadians

Published: 1 October 2018

Carriers at higher risk of developing neurodegenerative disease ...

A neurological disease paradigm shift

Published: 23 January 2024

Researchers propose a new model for classifying Parkinson’s...

RNA therapy may be a solution for infant hydrocephalus

Published: 29 January 2026

For the first time, drug targeting genetic mutation shown to have positive impact in mice models ...

Discovery gives answers to parents of children with rare disease

26 Aug 2024

Scientists identify gene mutations that cause debilitating neurodevelopmental problems in infancy.

A protective mechanism against spinocerebellar ataxia

30 Jul 2024

A recent study has discovered a genetic mechanism that protects people from developing a type of spinocerebellar ataxia, a mechanism that one third of the population lack.

Repressing a faulty gene

18 Mar 2024

A study underway at The Neuro is the first in Canada to evaluate whether a treatment using an antisense oligonucleotide therapy would be effective against Creutzfeldt-Jakob Disease.

Neurodegenerative gene focus of new Open Science project

15 Dec 2023

A new project led by scientists at The Neuro is zeroing in on a gene important to the study of neurological diseases.

Pages

The Neuro logo McGill logoMcGill University Health Centre logoKillam Laureates

 

The Neuro (Montreal Neurological Institute-Hospital) is a bilingual academic healthcare institution. We are a McGill research and teaching institute; delivering high-quality patient care, as part of the Neuroscience Mission of the McGill University Health Centre. We are proud to be a Killam Institution, supported by the Killam Trusts.

 

 

Facebook instagram blue sky iconx, formerly known as twitter linkedIn youtube

Back to top